Evidence map›Paper›PMID 41669298›Full record

ArticleAdvanced biomedical research2025

Fereshteh Ramezani Zardanjani, Hajar Yaghoobi, Abbas Alibakhshi, Sayedeh Azimeh Hosseini, Nayereh Bahamin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced biomedical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Antibacterial and Anticancer Potential ofInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fereshteh Ramezani ZardanjaniMedical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Hajar YaghoobiClinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Abbas AlibakhshiMolecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Sayedeh Azimeh HosseiniCellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Nayereh BahaminDepartment of Biochemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study investigates the anticancer effects of hydroalcoholic Materials and Methods: Signaling pathways in non-small-cell lung cancer were analyzed using the EnrichR website and KEGG algorithms associated with the GSE50627 dataset. The protein-protein interaction network was analyzed using STRING software. The compounds in Results: The PI3K-Akt signaling was the most prevalent pathway in GSE50627, associated with non-small-cell lung cancer. Results showed the inhibitory potential of Conclusion: Therefore, the hydroalcoholic extract of

Indexed as

A549 cell lineAlhagi maurorumlung cancerPTEN

Identifiers

PMID41669298
PMCPMC12885211

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.